These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10642432)

  • 1. The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy.
    Dunn SE; Torres JV; Nihei N; Barrett JC
    Mol Carcinog; 2000 Jan; 27(1):10-7. PubMed ID: 10642432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
    Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
    Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.
    Nielsen TO; Andrews HN; Cheang M; Kucab JE; Hsu FD; Ragaz J; Gilks CB; Makretsov N; Bajdik CD; Brookes C; Neckers LM; Evdokimova V; Huntsman DG; Dunn SE
    Cancer Res; 2004 Jan; 64(1):286-91. PubMed ID: 14729636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.
    Martens JW; Sieuwerts AM; Bolt-deVries J; Bosma PT; Swiggers SJ; Klijn JG; Foekens JA
    Thromb Haemost; 2003 Feb; 89(2):393-404. PubMed ID: 12574821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
    Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
    J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 (IGF-1) and urokinase-type plasminogen activator (uPA) are inversely related in human breast fibroblasts.
    Sieuwerts AM; Klijn JG; Foekens JA
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):179-85. PubMed ID: 10509812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER.
    Long BJ; Rose DP
    Cancer Lett; 1996 Feb; 99(2):209-15. PubMed ID: 8616826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
    Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
    Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
    Wang Y; Dang J; Liang X; Doe WF
    Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C; Sirchia R; Pupello D
    J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
    Konecny G; Untch M; Arboleda J; Wilson C; Kahlert S; Boettcher B; Felber M; Beryt M; Lude S; Hepp H; Slamon D; Pegram M
    Clin Cancer Res; 2001 Aug; 7(8):2448-57. PubMed ID: 11489825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor.
    Watabe T; Yoshida K; Shindoh M; Kaya M; Fujikawa K; Sato H; Seiki M; Ishii S; Fujinaga K
    Int J Cancer; 1998 Jul; 77(1):128-37. PubMed ID: 9639404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat.
    Holst-Hansen C; Low JA; Stephens RW; Johnson MD; Carmeliet P; Frandsen TL; Brünner N; Dickson RB
    Breast Cancer Res Treat; 2001 Aug; 68(3):225-37. PubMed ID: 11727959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.